ID Pharma (Japan)

Recent papers from ID Pharma (Japan)

1. IRO-203: a novel intranasal COVID-19 vaccine showing immunogenicity and viral suppression in African green monkey challenge studyScientific Reports · 2026
2. On-site recycling of construction surplus soil in winged composite piles for enhanced uplift resistanceCleaner Engineering and Technology · 2026
3. A Review of Thermal–Hydrological–Mechanical–Chemical Coupling Studies on the Geological Disposal of Radioactive Waste in JapanRock Mechanics and Rock Engineering · 2026
4. The precision strategy of human genome correction via a set of circular donor DNA and its cleaverFrontiers in Genome Editing · 2026
5. SART1 uniquely localizes to spindle poles forming a SART1 cap and promotes spindle pole assemblyJournal of Biological Chemistry · 2025
6. H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotencyStem Cell Reports · 2024
7. A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosisEmerging Microbes & Infections · 2024
8. SART1 localizes to spindle poles forming a SART1 cap and promotes spindle pole assembly2023
9. Evaluation of Drug‐Drug Interactions of Ensitrelvir, a SARS‐CoV‐2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical StudiesThe Journal of Clinical Pharmacology · 2023
10. CD96 Blockade Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis via Suppression of IL-17A Production by Dermal γδ T CellsThe Journal of Immunology · 2022
11. Improved Sendai viral system for reprogramming to naive pluripotencyCell Reports Methods · 2022
12. Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8+ T cells but not CD4+ T cellsMolecular Therapy · 2022
13. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responsesCell Reports Medicine · 2022
14. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditionsProceedings of the National Academy of Sciences · 2021
15. iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibilityFEBS Open Bio · 2021
16. Suppression of Th1 and Th17 Proinflammatory Cytokines and Upregulation of FOXP3 Expression by a Humanized Anti-DNAM-1 Monoclonal AntibodyMonoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2021
17. Development of intranasal Sendai virus vector-based vaccine against COVID-19Translational and Regulatory Sciences · 2021
18. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector BoostsJournal of Virology · 2020
19. Therapeutic vaccine-mediated Gag-specific CD8+ T-cell induction under anti-retroviral therapy augments anti-virus efficacy of CD8+ cells in simian immunodeficiency virus-infected macaquesScientific Reports · 2020
20. A Novel Immunogen Selectively Eliciting CD8 ⁺ T Cells but Not CD4 ⁺ T Cells Targeting Immunodeficiency Virus AntigensJournal of Virology · 2020